The OriGen Reinforced Dual Lumen catheter (RDLC) is a duel lumen catheter with a wire reinforceme...

FDA Device Recall #Z-0021-2018 — Class I — August 2, 2017

Recall Summary

Recall Number Z-0021-2018
Classification Class I — Serious risk
Date Initiated August 2, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm OriGen Biomedical, Inc.
Location Austin, TX
Product Type Devices
Quantity 180 units

Product Description

The OriGen Reinforced Dual Lumen catheter (RDLC) is a duel lumen catheter with a wire reinforcement layer on the tip of the device. A thin sheath is used to cover and secure the wire layer and is heat shrunk into a permanent position.

Reason for Recall

Two users have reported to OriGen that a VV28F OriGen Reinforced Dual Lumen ECMO Catheter has had a separation of the clear extension tube from the hub connection. These adverse events resulted in patient injury (blood loss).

Distribution Pattern

US Nationwide and the countries of Austria, Belgium, Chile, Czech Republic, Italy, Kingdom of Saudi Arabia, Netherlands, Poland, Sweden, Thailand, Colombia, India, South Africa, United Arab Emirates.

Lot / Code Information

Lot Numbers: N18487, N18487-1

Other Recalls from OriGen Biomedical, Inc.

Recall # Classification Product Date
Z-1068-2024 Class II Accessory Sets Syringes: 6ml syringe with a fem... Dec 19, 2023
Z-1409-2021 Class III Evolve Cell Culture Bags, part numbers: EV1000... Jan 28, 2021
Z-0318-2021 Class II 3/8" FloPump, 32mL, (Sterile), REF 6400S, UDI: ... Jun 24, 2019
Z-0180-2019 Class II Reinforced Dual Lumen Cannula, 16Fr., REF: VV16... Aug 21, 2018
Z-0182-2019 Class II Reinforced Dual Lumen Cannula, 23Fr., REF: VV23... Aug 21, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.